Home » Amphastar, Watson Renew Appeal to Lift Generic Lovenox Ban
Amphastar, Watson Renew Appeal to Lift Generic Lovenox Ban
Amphastar and Watson Pharmaceuticals are again appealing a federal court’s decision to uphold an injunction barring them from selling generic versions of Sanofi’s blockbuster blood-thinner Lovenox.
Generic Line
Generic Line
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May